Advertisement
Canada markets close in 4 hours 43 minutes

  • S&P/TSX

    21,630.46
    +113.56 (+0.53%)
     

  • S&P 500

    5,497.06
    +10.03 (+0.18%)
     

  • DOW

    38,934.50
    +99.64 (+0.26%)
     

  • CAD/USD

    0.7302
    +0.0004 (+0.06%)
     

  • CRUDE OIL

    82.31
    +0.74 (+0.91%)
     

  • Bitcoin CAD

    88,949.19
    -162.53 (-0.18%)
     

  • CMC Crypto 200

    1,348.55
    -34.12 (-2.47%)
     

  • GOLD FUTURES

    2,378.30
    +31.40 (+1.34%)
     

  • RUSSELL 2000

    2,029.35
    +4.12 (+0.20%)
     

  • 10-Yr Bond

    4.2810
    +0.0640 (+1.52%)
     

  • NASDAQ

    17,884.22
    +21.99 (+0.12%)
     

  • VOLATILITY

    12.90
    +0.42 (+3.37%)
     

  • FTSE

    8,268.37
    +63.26 (+0.77%)
     

  • NIKKEI 225

    38,633.02
    +62.26 (+0.16%)
     

  • CAD/EUR

    0.6813
    +0.0026 (+0.38%)
     
MARKETS LIVE BLOG:

S&P 500, NASDAQ EXTEND GAINS AS NVIDIA SURGE CONTINUES

Nvidia stock up 3% in early trading; shares have climbed more than 170% so far this year

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

Cue Biopharma, Inc.
·2 min read
Cue Biopharma, Inc.
Cue Biopharma, Inc.

BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells, today announced that it will participate in two investor conferences this June, the Jefferies Global Healthcare Conference, to be held in New York, NY, June 4-6 and the Oppenheimer Novel Targets and Immunology Summit, to be held in New York, NY on June 24.

Cue Biopharma will discuss current clinical and preclinical progress as well as strategy in the advancement of its oncology and autoimmune platforms and biologics.

Presentation Details
Jefferies Global Healthcare Conference
Date and Time: Thursday, June 6 from 2:00 – 2:25 p.m. EDT
Webcast Link: https://wsw.com/webcast/jeff302/cue/1681744 
Presenter: Anish Suri, Ph.D., president and chief scientific officer, Cue Biopharma

ADVERTISEMENT

Oppenheimer Novel Targets and Immunology Summit
Panel Presentation Date and Time: Monday, June 24 from 11:00 – 11:40 a.m. EDT
Panel: Repurposing Cancer Targets for Immunology
Presenter: Anish Suri, Ph.D., president and chief scientific officer, Cue Biopharma

A live and archived webcast of the presentation for the Jefferies Global Healthcare Conference will be available on the Events page in the Investors and Media section of the Company’s website at www.cuebiopharma.com. The webcast will be archived for 30 days.

About Cue Biopharma
Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body’s intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation.

Headquartered in Boston, Massachusetts, we are led by an experienced management team and independent Board of Directors with deep expertise in immunology and immuno-oncology as well as the design and clinical development of protein biologics.

For more information please visit www.cuebiopharma.com and follow us on X and LinkedIn.

Investor Contact
Marie Campinell
Senior Director, Corporate Communications
Cue Biopharma, Inc.
mcampinell@cuebio.com

Media Contact
Jonathan Pappas
LifeSci Communications
jpappas@lifescicomms.com